Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.
One hundred and fifty-eight dysgerminomas from the Emil Novak Ovarian Tumor Registry and the Gynecologic Pathology Laboratory of The Johns Hopkins Hospital were reviewed. Five-year follow-up was available for 82% and 10-year follow-up was available for 65%, with survival rates of 83% and 74% for pure tumors, respectively. Survival was related to stage of disease and presence of other germ cell elements. Patients treated by unilateral adnexectomy alone for stage IA pure dysgerminoma had a 95% 5-year survival. Survival of these patients was not affected by tumor size.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D012734:Disorders of Sex Development / Q000150:complications; D004407:Dysgerminoma / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D005260:Female; D005298:Fertility; D006801:Humans; D008396:Maryland; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D012042:Registries